Krishna Institute of Medical Sciences Ltd

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Krishna Institute of Medical Sciences (KIMS) shows robust EBITDA growth of 27% YoY, prompting a revised target price of Rs 675/share. New leadership and clinical talent hiring across regions are expected to enhance profitability and revenue. The management anticipates a 22% EBITDA CAGR over FY24-27E, with a focus on achieving faster breakeven in new clusters. However, delays in breakeven remain a key risk.

KIMS Reports Strong Growth and Revised Target Price - 12 Nov, 2024

Krishna Institute of Medical Sciences (KIMS) reported strong Q2 FY25 results, with significant increases in revenue and net profit. The stock initially surged but ended lower, reflecting market volatility despite positive financial performance.

KIMS Reports Strong Q2 Results, Stock Volatile - 11 Nov, 2024

Krishna Institute of Medical Sciences (KIMS) Hospitals plans to expand into Kerala, establishing 3,000 beds and creating 10,000 jobs over the next five years.

KIMS Hospitals Expands Operations in Kerala - 07 Nov, 2024

KIMS Hospitals is expanding into Kerala, planning to establish 3,000 new beds over five years. The company has begun operations by acquiring Sreechand Hospital and entering an O&M contract with Westfort Hospital. Future plans include developing health cities and specialized centers in various districts.

KIMS Hospitals Expands Operations in Kerala - 06 Nov, 2024

Krishna Institute of Medical Sciences (KIMS) shows robust Q1FY25 performance with a 12.9% YoY net income growth. Recent acquisitions and partnerships enhance market position.

KIMS Reports Strong Q1 Performance and Strategic Acquisitions - 19 Oct, 2024

Krishna Institute of Medical Sciences has entered a ₹700 crore agreement with Wipro GE Healthcare for medical technology procurement, covering existing and upcoming facilities over three years.

KIMS Hospitals Secures ₹700 Crore Tech Deal - 18 Oct, 2024

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Mutual Funds have increased holdings from 25.30% to 25.77% in Sep 2024 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Up

Netprofit is up for the last 3 quarters, 65.5 Cr → 107.4 Cr (in ₹), with an average increase of 21.9% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Spike

Retail Investor have increased holdings from 11.22% to 13.03% in Sep 2024 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Up

In the last 3 months, KIMS stock has moved up by 16.5%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Rise

Revenue is up for the last 4 quarters, 609.09 Cr → 782.3 Cr (in ₹), with an average increase of 8.0% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Rich

Promoters holdings remained unchanged at 38.82% of holdings in Sep 2024 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Unchanged

Foreign Institutions have decreased holdings from 17.84% to 15.85% in Sep 2024 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

S&P BSE 250 SmallCap

Nifty MidSmallcap 400

BSE Healthcare

Nifty 500

S&P BSE SmallCap Select

BSE Small-Cap

S&P BSE 400 MidSmallCap

Nifty Smallcap 250

S&P BSE AllCap

BSE 500

SBI Small Cap Fund Direct Plan Growth

HDFC Small Cap Fund-Direct Growth Option

Axis Small Cap Fund Direct Growth

SBI Multicap Fund Direct Growth

Kotak Small Cap Direct Growth

Krishna Institute of Medical Sciences Ltd’s net profit jumped 16.71% since last year same period to ₹107.40Cr in the Q2 2024-2025. On a quarterly growth basis, Krishna Institute of Medical Sciences Ltd has generated 24.02% jump in its net profits since last 3-months.

Name	Value	Action
MACD level (12,26)	-0.75	Bearish
CCI (20)	-147.43	Bullish
RSI (14)	53.96	Neutral
Momentum (10)	0.55	Bullish
ADI (14)	54.12	Bearish
Ultimate Oscillator (7,14,28)	63.36	Neutral

Name	Value	Action
SMA (20)	583.22	Bullish
EMA (20)	582.88	Bullish
VWMA (20)	582.51	Bullish
SMA (50)	584.21	Bearish
EMA (50)	583.71	Bullish
SMA (200)	583.71	Bullish
EMA (200)	583.13	Bullish
KAMA (200)	584.31	Bearish
DEMA (200)	585.54	Bearish

Krishna Institute of Medical Sciences Ltd (KIMS)

Summary

Overall

Oscillators

Moving Averages